AIM ImmunoTech Inc. AIM

Full chart Compare
Set alert

Price alert · AIM

All alert types
0.16 USD 0.00 (+0.19%)

At closeNov 4, 2026, 7:53 PM EST

0.16 0.00 -0.62%

After hours · Nov 4, 7:53 PM ET

0.1607 Day range 0.1678
0.15 52-week range 1.82
YTD
-85.36%
1 year
-89.61%

Revenue & Expenses

Other Operating Income → Expenses: $1.35MExpenses → Gross Loss: $250.00KExpenses → Selling, General & Admin: $7.70MExpenses → Research & Development: $3.92MExpenses → Interest Expense: $812.00KExpenses → Other Expenses: $2.62MNet Loss → Expenses: $13.96MRevenue → Cost of Revenue: $88.00KOther Operating Income$1.35MNet Loss$13.96MCost of Revenue$338.00KExpenses$15.31MGross Loss$250.00KSelling, General & Admin$7.70MResearch & Development$3.92MInterest Expense$812.00KOther Expenses$2.62MRevenue$88.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

AIM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
88.00K170.00K202.00K141.00K135.00K
-40.00K139.00K160.00K141.00K-715.00K
-11.66M-19.77M-31.90M-19.92M-18.62M
-13.96M-17.32M-28.96M-19.45M-19.13M
-8.62-30.92-60.00-40.00-40.00
AIM annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.98M1.70M5.44M27.05M32.09M
5.78M8.61M19.38M40.49M57.70M
15.56M9.93M9.15M2.02M820.00K
4.90M2.94M718.00K837.00K149.00K
-9.78M-1.32M10.23M38.47M56.88M
AIM annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-10.96M-14.89M-21.27M-16.11M-13.96M
1.85M4.71M-832.00K10.99M-631.00K
10.39M6.44M485.00K80.00K8.19M
1.28M-3.74M-21.61M-5.04M-6.41M